Publications
-
Celis-Passini V, de Torres C, Parareda A, Rodriguez N, Torner-Rubies F, Cruz-Martínez O and Mora J.
Treatment of Newly Diagnosed Ewing Sarcoma with Gemcitabine and Docetaxel as an Alternative to Conventional Therapy in 2 patients Who Did Not Wish to Undergo Intensive Chemotherapy
Oncopedia . : 584.
-
Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, Kiezun A, Hammerman PS, McKenna A, Drier Y, Zou L, Ramos AH, Pugh TJ, Stransky N, Helman E, Kim J, Sougnez C, Ambrogio L, Nickerson E, Shefler E, Cortés ML, Auclair D, Saksena G, Voet D, Noble M, DiCara D, Lin P, Lichtenstein L, Heiman DI, Fennell T, Imielinski M, Hernandez B, Hodis E, Baca S, Dulak AM, Lohr J, Landau DA, Wu CJ, Melendez-Zajgla J, Hidalgo-Miranda A, Koren A, McCarroll SA, Mora J, Lee RS, Crompton B, Onofrio R, Parkin M, Winckler W, Ardlie K, Gabriel SB, Roberts CW, Biegel JA, Stegmaier K, Bass AJ, Garraway LA, Meyerson M, Golub TR, Gordenin DA, Sunyaev S, Lander ES and Getz G.
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Nature . 499(7457): 214-218. Number of citations: 4529
-
Masvidal L, Iniesta R, Casalà C, Galván P, Rodriguez E, Lavarino C, Mora J and de Torres C.
Polymorphisms in the Calcium-Sensing Receptor Gene Are Associated with Clinical Outcome of Neuroblastoma
PLoS One . 8(3): . Number of citations: 14
-
Casalà C, Gil-Guiñón E, Ordóñez JL, Miguel-Queralt S, Rodriguez E, Galván P, Lavarino C, Munell F, de Alava E, Mora J and de Torres C.
The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis
Carcinogenesis . 34(2): 268-276. Number of citations: 38
-
Mora J.
What is a pediatric tumor?
Clinical Oncology in Adolescents and Young Adults . 2: 7-15.
-
Mayol G, Martín-Subero JI, Ríos J, Queiros A, Kulis M, Suñol M, Esteller M, Gomez-Gonzalez S, Garcia I, de Torres C, Rodriguez E, Galván P, Mora J and Lavarino C.
DNA Hypomethylation Affects Cancer-Related Biological Functions and Genes Relevant in Neuroblastoma Pathogenesis
PLoS One . 7(11): . Number of citations: 36
-
Lee RS, Stewart C, Carter SL, Ambrogio L, Cibulskis K, Sougnez C, Lawrence MS, Auclair D, Mora J, Golub TR, Biegel JA, Getz G and Roberts CW.
A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers
JOURNAL OF CLINICAL INVESTIGATION . 122(8): 2983-2988. Number of citations: 364
-
Garcia I, Mayol G, Ríos J, Domenech G, Cheung NK, Oberthuer A, Fischer M, Maris JM, Brodeur GM, Hero B, Rodriguez E, Suñol M, Galvan P, de Torres C, Mora J and Lavarino C.
A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma
CLINICAL CANCER RESEARCH . 18(7): 2012-2023. Number of citations: 55
-
Mora J, Rodriguez E, de Torres C, Cardesa-Salzmann TM, Ríos J, Hernández T, Cardesa A and de Alava E.
Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome
PEDIATRIC BLOOD & CANCER . 58(4): 532-538. Number of citations: 25
-
Fernandez AF, Assenov Y, Martin-Subero JI, Balint B, Siebert R, Taniguchi H, Yamamoto H, Hidalgo M, Tan AC, Galm O, Ferrer I, Sanchez-Cespedes M, Villanueva A, Carmona J, Sanchez-Mut JV, Berdasco M, Moreno V, Capella G, DAVID NICHOLAS MONK, Ballestar E, Ropero S, Martinez R, Sanchez-Carbayo M, Prosper F, Agirre X, Fraga MF, Graña O, Perez-Jurado L, Mora J, Puig S, Prat J, Badimon L, Puca AA, Meltzer SJ, Lengauer T, Bridgewater J, Bock C and Esteller M.
A DNA methylation fingerprint of 1628 human samples
GENOME RESEARCH . 22(2): 407-419. Number of citations: 355